Multiple genetic studies in humans indicate a role for solute carrier family 11a member 1 [SLC11A1; formerly
natural resistance-associated macrophage protein 1 (NRAMP1)] in
autoimmune disease susceptibility, including
ulcerative colitis. Murine Slc11a1 has many pleiotropic effects on macrophage activation and proinflammatory responses. To determine which of these are important in
ulcerative colitis, we established a phenotype for oral
dextran sulfate sodium (DSS)-induced acute
colitis in congenic Slc11a1 wild-type (wt) and mutant (mt) mice on a B10 background. For over 7 days of treatment with 2% DSS in the
drinking water, Slc11a1 wt mice showed enhanced acute
ulcerative colitis, as demonstrated by significantly greater
body weight loss and reduction in colon length, as well as a marked increase in monocyte/macrophage inflammatory infiltrates and histopathology changes in the colon. This was accompanied by a clear, inverse relationship between IFN-gamma and
IL-10 responses in Slc11a1 wt compared with mt mice, resulting in a significantly higher ratio of IFN-gamma:IL-10 in wt compared with mt mice in lymph node and splenic T cells.
RNase protection assays confirmed the presence of significantly higher IFN-gamma at the
RNA level in the colons of wt compared with mt mice at Day 7 of treatment. Interestingly this was accompanied by significantly enhanced
RNA levels for the
acute-phase protein IL-6, which is known to inhibit the generation of forkhead box P3+ regulatory T cells and help to drive the differentiation of Th17 from naive T cells and not by differences in
RNA for
IL-12p35 or
IL-12p40 molecules that dimerize to form the Th1-inducing
cytokine IL-12.